Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

PeptiDream stock

4587.T
JP3836750004
A1W0KK

Price

2,700.00
Today +/-
-0.83
Today %
-4.98 %
P

PeptiDream stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the PeptiDream stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the PeptiDream stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the PeptiDream stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze PeptiDream's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

PeptiDream Stock Price History

DatePeptiDream Price
11/1/20242,700.00 undefined
10/31/20242,838.00 undefined
10/30/20242,835.00 undefined
10/29/20242,837.00 undefined
10/28/20242,781.00 undefined
10/25/20242,685.50 undefined
10/24/20242,754.00 undefined
10/23/20242,818.50 undefined
10/22/20242,842.50 undefined
10/21/20242,968.00 undefined
10/18/20242,950.00 undefined
10/17/20242,942.00 undefined
10/16/20242,857.00 undefined
10/15/20242,913.00 undefined
10/11/20242,740.00 undefined
10/10/20242,720.50 undefined
10/9/20242,739.50 undefined
10/8/20242,742.00 undefined
10/7/20242,858.50 undefined

PeptiDream Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into PeptiDream, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by PeptiDream from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects PeptiDream’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of PeptiDream. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into PeptiDream’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing PeptiDream’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on PeptiDream’s growth potential.

PeptiDream Revenue, EBIT and net profit per share

DatePeptiDream RevenuePeptiDream EBITPeptiDream Net Income
2026e44.31 B undefined0 undefined12.92 B undefined
2025e41.61 B undefined0 undefined11.57 B undefined
2024e46.62 B undefined0 undefined14.85 B undefined
202328.71 B undefined6.81 B undefined3.04 B undefined
202226.85 B undefined8.97 B undefined7.55 B undefined
20219.42 B undefined4.06 B undefined2.57 B undefined
202011.68 B undefined6.99 B undefined4.45 B undefined
20191.04 B undefined-887.17 M undefined-488.46 M undefined
20187.22 B undefined3.58 B undefined2.77 B undefined
20176.43 B undefined2.91 B undefined2.34 B undefined
20164.9 B undefined2.49 B undefined1.89 B undefined
20154.33 B undefined2.55 B undefined1.58 B undefined
20142.47 B undefined1.39 B undefined1 B undefined
2013818.9 M undefined201.4 M undefined148.5 M undefined
2012678.3 M undefined160.8 M undefined137.2 M undefined
2011269 M undefined-18.2 M undefined10 M undefined
2010601.5 M undefined348.6 M undefined176.1 M undefined
200991.1 M undefined-33.5 M undefined-19 M undefined
200886.9 M undefined-22.5 M undefined-21.9 M undefined
200760.1 M undefined3.3 M undefined2.4 M undefined

PeptiDream Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
0.060.090.090.60.270.680.822.474.334.96.437.221.0411.689.4226.8528.7146.6241.6144.31
-43.335.81560.44-55.24152.0420.65202.4474.9013.1331.2812.29-85.631,026.04-19.31184.996.9362.36-10.746.47
51.6744.1930.7780.2037.5560.4761.6170.8274.9072.2272.3377.1235.2081.6074.5967.4559.97---
0.030.040.030.480.10.410.51.753.243.544.655.570.379.537.0318.1117.22000
0-0.02-0.030.35-0.020.160.21.392.552.492.913.58-0.896.994.068.976.81000
5.00-25.58-36.2657.90-6.6923.6024.5756.1058.8950.8745.2849.60-85.5459.8743.0533.4223.72---
0-0.02-0.020.180.010.140.1511.581.892.342.77-0.494.452.577.553.0414.8511.5712.92
--1,150.00-9.52-1,026.32-94.321,270.008.03578.3857.4719.5423.5418.63-117.62-1,011.48-42.15193.59-59.82389.16-22.0911.67
65.673.676.884.385.6111.3108.7128.25128.98129.82131.23129.85125.17129.83129.93129.94129.84000
--------------------
Details

Keystats

Revenue and Growth

The PeptiDream Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the PeptiDream is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20072008200920102011201220132014201520162017201820192020202120222023
                                 
0.010.210.130.460.235.575.65.886.916.563.516.856.997.1511.825.2519.51
0.0100.020.070.040.150.180.351.41.753.092.980.315.660.8116.594.97
00000000000001.880.0100
00000000000.170.290.340.590.932.682.4
0000.010.030.040.050.140.290.211.290.260.40.380.270.550.34
0.030.210.150.540.35.765.836.368.68.528.0610.378.0415.6413.8425.0727.23
000.010.120.110.170.171.363.144.866.145.855.735.776.4418.1317.36
00000000001.93.183.24.16.686.5211.88
0000000010010010010095.84152.4000
0.010.010.01000000.020.060.070.10.10.080.082.232.21
000000000.080.060.040.020.01008.378.37
00000000.010.010.030.180.420.640.5203.542.42
0.010.010.010.120.110.170.171.373.365.118.449.679.7810.6313.238.7942.24
0.040.220.160.660.415.9367.7411.9613.6316.520.0417.8226.2727.0363.8769.46
                                 
0.030.110.110.110.112.732.732.753.633.873.923.933.933.933.963.963.96
0.030.10.10.110.112.722.732.753.633.873.913.933.933.934.454.524.55
-0.02-0.04-0.060.120.110.250.41.422.994.877.2910.069.5714.0216.3723.8527.8
000000000000001.190.325.12
00000000000-58.4-40.7-13.13000
0.040.170.150.330.335.75.866.9110.2412.6115.1217.8617.3921.8725.9732.6541.44
001428916.0110.223.7936.2263.0138.655.28100.87641.11300.18
01625173841148.09247.57342.470000000
00.050.010.30.060.180.090.661.440.981.682.380.644.651.287.75.73
0000000000000005000
0000000000000002.192.59
00.050.010.330.080.230.140.831.71.351.712.440.684.711.3811.038.62
00000000000000018.3619.63
00000000000000308.30385.84
000000000.020.10.080.150.160.3402.440.48
000000000.020.10.080.150.160.340.3120.7920.5
00.050.010.330.080.230.140.831.711.451.792.590.845.051.6831.8229.11
0.040.220.160.660.415.9367.7411.9614.0616.9120.4518.2326.9227.6564.4770.55
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of PeptiDream provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand PeptiDream's financial health and stability.

Assets

PeptiDream's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that PeptiDream must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of PeptiDream after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into PeptiDream's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201020112012201320142015201620172018null20192020202120222023
0.34-0.020.170.221.492.372.623.153.813.81-0.716.023.86.654.35
0.020.040.050.070.10.140.190.510.520.520.260.570.631.972.43
000000000000000
0.06-0.18-0-0.21-0.12-1.05-1.38-2.640.190.190.72-6.081.81-8.935.32
0.010.010.01-0.02-0.090.080.090-0.04-0.04-0.031.230.410.220.31
0000000000000148181
00.130.040.080.040.731.160.540.890.890.730.012.380.393.67
0.43-0.150.230.071.391.531.531.024.484.480.241.736.65-0.0812.42
-95-56-112-73-1,238-1,968-1,934-2,471-195-195-138-586-1,214-3,975-1,368
-0.1-0.06-0.11-3.470.96-0.98-1.94-4.25-1.26-1.26-0.14-1.2-2.28-27.381.3
000-3.42.20.99-0-1.77-1.06-1.060-0.61-1.07-23.42.67
000000000000000
0000000000000210.82
0.0105.20.020.041.740.050.170.030.030-0.240.040-0.51
0.01-0.025.190.020.041.740.050.170.030.030-0.240.0720.790.26
-20-1400000000021-212-38
0-160000000000000
0.33-0.235.34-3.372.482.23-0.35-3.053.353.350.130.164.6-6.514.26
330.2-207.3122-0.9147.87-435.6-403.82-1,448.994,285.920103.731,146.475,440.03-4,058.3511,052.01
000000000000000

PeptiDream stock margins

The PeptiDream margin analysis displays the gross margin, EBIT margin, as well as the profit margin of PeptiDream. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for PeptiDream.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the PeptiDream's sales revenue. A higher gross margin percentage indicates that the PeptiDream retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the PeptiDream's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the PeptiDream's total revenue generated. When comparing the revenue margin year over year, investors can gauge the PeptiDream's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the PeptiDream. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the PeptiDream's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

PeptiDream Margin History

PeptiDream Gross marginPeptiDream Profit marginPeptiDream EBIT marginPeptiDream Profit margin
2026e59.97 %0 %29.15 %
2025e59.97 %0 %27.79 %
2024e59.97 %0 %31.85 %
202359.97 %23.72 %10.57 %
202267.46 %33.42 %28.13 %
202174.6 %43.06 %27.31 %
202081.61 %59.87 %38.09 %
201935.28 %-85.52 %-47.09 %
201877.12 %49.6 %38.39 %
201772.33 %45.29 %36.34 %
201672.22 %50.87 %38.62 %
201574.9 %58.88 %36.54 %
201470.84 %56.1 %40.58 %
201361.56 %24.59 %18.13 %
201260.55 %23.71 %20.23 %
201137.77 %-6.77 %3.72 %
201080.2 %57.96 %29.28 %
200930.95 %-36.77 %-20.86 %
200843.96 %-25.89 %-25.2 %
200751.58 %5.49 %3.99 %

PeptiDream Stock Sales Revenue, EBIT, Earnings per Share

The PeptiDream earnings per share therefore indicates how much revenue PeptiDream has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue PeptiDream earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates PeptiDream's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of PeptiDream’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating PeptiDream's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

PeptiDream Revenue, EBIT and net profit per share

DatePeptiDream Sales per SharePeptiDream EBIT per sharePeptiDream Earnings per Share
2026e341.83 undefined0 undefined99.65 undefined
2025e321.06 undefined0 undefined89.24 undefined
2024e359.68 undefined0 undefined114.55 undefined
2023221.13 undefined52.46 undefined23.38 undefined
2022206.66 undefined69.06 undefined58.14 undefined
202172.52 undefined31.22 undefined19.81 undefined
202089.94 undefined53.85 undefined34.26 undefined
20198.29 undefined-7.09 undefined-3.9 undefined
201855.58 undefined27.57 undefined21.33 undefined
201748.97 undefined22.18 undefined17.79 undefined
201637.71 undefined19.18 undefined14.56 undefined
201533.56 undefined19.76 undefined12.26 undefined
201419.29 undefined10.82 undefined7.83 undefined
20137.53 undefined1.85 undefined1.37 undefined
20126.09 undefined1.44 undefined1.23 undefined
20113.14 undefined-0.21 undefined0.12 undefined
20107.14 undefined4.14 undefined2.09 undefined
20091.19 undefined-0.44 undefined-0.25 undefined
20081.18 undefined-0.31 undefined-0.3 undefined
20070.92 undefined0.05 undefined0.04 undefined

PeptiDream business model

PeptiDream Inc is a Japanese biotech company specializing in novel therapeutics and drugs. The company was founded in 2006 by Professor Hiroaki Suga, who established the field of peptide synthesis at the University of Tokyo. Peptides are short chains of amino acids used in pharmaceutical development and diagnosis. PeptiDream uses a patented technology to generate billions of different peptides, which can then be systematically tested for functionality and applicability. The company also utilizes artificial intelligence and machine learning to specifically find compounds that can potentially treat cancer or neurodegenerative diseases. PeptiDream has four diverse business areas focusing on different applications. The first area is the identification of new drugs, where the company collaborates with several pharmaceutical and biotech firms to develop new compounds. The second area focuses on the development of peptide-based diagnostics. An example of this is the PeelAVERT technology, which identifies cancer-causing proteins through a "peeling process" of skin samples. This allows for personalized cancer treatment and improves success rates. The third area involves the development of agrochemicals. PeptiDream aims to replace chemical pesticides with biodegradable peptide-based compounds that have no negative impact on the environment. The fourth area aims to enhance quality of life through the use of peptides. The company focuses on compounds that can strengthen the immune system or slow down the aging process. PeptiDream has made several groundbreaking discoveries, including the PD-1 inhibitor technology for cancer treatment. This method uses peptides to activate the body's immune system and kill cancer cells. PD-1 inhibitors have shown promising results in clinical studies for lung cancer, kidney cancer, and other tumor types. PeptiDream has also developed a technology called "Peptide Discovery Platform System 2.0," which allows for the rapid generation and analysis of billions of diverse peptides. This method has been patented and enables PeptiDream to quickly focus on the development of new compounds. PeptiDream is a global leader in the development of peptide therapeutics and diagnostics. The company has earned an excellent reputation and collaborates closely with various research institutions, pharmaceutical companies, and biotech firms. PeptiDream also invests in training the next generation of scientists and strives to provide the industry and society with new compounds. PeptiDream is one of the most popular companies on Eulerpool.com.

PeptiDream SWOT Analysis

Strengths

PeptiDream Inc has a strong reputation in the biopharmaceutical industry, recognized for its innovative peptide drug discovery technologies.

The company has a robust and diverse pipeline of potential drug candidates, which positions it well for future growth.

PeptiDream Inc benefits from strategic collaborations with major pharmaceutical companies, providing access to additional resources and expertise.

Weaknesses

PeptiDream Inc may face challenges in scaling up its production processes to meet commercial demand for its peptide drugs.

The company's heavy reliance on collaborations for revenue generation exposes it to potential risks if these partnerships fail to deliver expected results or terminate.

PeptiDream Inc's limited global presence and market penetration may hinder its ability to compete effectively against larger, more established competitors.

Opportunities

The increasing focus on personalized medicine and targeted therapies presents significant opportunities for PeptiDream Inc's peptide drug discovery technologies.

Expansion into emerging markets, where access to advanced biopharmaceuticals is growing, could open up new avenues for revenue and market share growth.

PeptiDream Inc has the potential to leverage its expertise in peptide drug discovery to explore applications in other therapeutic areas, diversifying its product offerings.

Threats

PeptiDream Inc operates in a highly competitive industry, facing constant challenges from other biopharmaceutical companies in developing and commercializing innovative drugs.

The regulatory environment governing drug development and approval can present obstacles and delays for PeptiDream Inc's pipeline candidates, impacting their time-to-market and potential profitability.

Unexpected scientific or technological breakthroughs by competitors could render PeptiDream Inc's current peptide drug discovery technologies obsolete.

PeptiDream Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

PeptiDream historical P/E ratio, EBIT multiple, and P/S ratio

PeptiDream shares outstanding

The number of shares was PeptiDream in 2023 — This indicates how many shares 129.841 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue PeptiDream earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates PeptiDream's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of PeptiDream’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating PeptiDream's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

PeptiDream stock splits

In PeptiDream's history, there have been no stock splits.

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for PeptiDream.

PeptiDream latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024128.67 144.8  (12.53 %)2024 Q2
3/31/20240.68 -6.5  (-1,049.98 %)2024 Q1
12/31/202311.04 -3.9  (-135.34 %)2023 Q4
12/31/20215.23 1.83  (-64.99 %)2021 Q4
9/30/202120.9 19.97  (-4.46 %)2021 Q3
6/30/2021-0.17 2.59  (1,610.38 %)2021 Q2
3/31/20213.29 3.43  (4.28 %)2021 Q1
12/31/202027.7 29.82  (7.64 %)2020 Q4
9/30/20209.88 -1.51  (-115.29 %)2020 Q3
6/30/20206.68 9.8  (46.79 %)2020 Q2
1
2

Eulerpool ESG Scorecard© for the PeptiDream stock

Eulerpool World ESG Rating (EESG©)

71/ 100

🌱 Environment

99

👫 Social

56

🏛️ Governance

58

Environment

Scope 1 - Direct Emissions
1,984
Scope 2 - Indirect emissions from purchased energy
6,385
Scope 3 - Indirect emissions within the value chain
46
Total CO₂ emissions
8,369
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees39.3
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

PeptiDream shareholders

%
Name
Stocks
Change
Date
9.63419 % Kubota (Kiichi)12,487,000-500,0006/30/2024
9.21370 % Suga (Hiroaki)11,942,00006/30/2024
7.51423 % M&G Investment Management Ltd.9,739,300-58,6008/30/2024
4.55030 % Asset Management One Co., Ltd.5,897,7004,849,5229/13/2024
3.42555 % Sumitomo Mitsui Trust Asset Management Co., Ltd.4,439,900-579,9007/14/2023
3.37702 % Murakami (Hiroshi)4,377,00006/30/2024
3.23274 % Reid (Patrick)4,190,00006/30/2024
2.75076 % Baillie Gifford & Co.3,565,300-17,1008/31/2024
2.45748 % Nomura Asset Management Co., Ltd.3,185,17423,2009/30/2024
2.17634 % Norges Bank Investment Management (NBIM)2,820,780753,2096/30/2024
1
2
3
4
5
...
10

PeptiDream Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,69-0,140,15-0,72-0,72-0,76
SupplierCustomer0,630,490,38-0,080,49-0,39
SupplierCustomer0,630,290,09-0,49-0,20-0,51
SupplierCustomer0,620,910,11-0,65-0,36-0,08
SupplierCustomer0,550,64-0,33-0,670,350,17
SupplierCustomer0,450,800,360,37-0,37-0,76
SupplierCustomer0,440,870,29-0,24-0,200,45
SupplierCustomer0,430,620,230,220,910,92
SupplierCustomer0,39-0,560,330,850,570,07
SupplierCustomer0,340,660,280,740,650,61
1
2

Most common questions regarding PeptiDream

What values and corporate philosophy does PeptiDream represent?

PeptiDream Inc represents values of innovation, collaboration, and excellence in the field of peptide therapeutics. The company's corporate philosophy revolves around utilizing its proprietary Peptide Discovery Platform System (PDPS) to develop novel and optimized peptides for drug discovery and development. By leveraging their cutting-edge technology and expertise, PeptiDream Inc aims to advance therapeutic options for various diseases, including cancer, metabolic disorders, and autoimmune conditions. The company emphasizes the importance of partnerships with biopharmaceutical companies, academia, and other stakeholders to accelerate the translation of discoveries into potential life-saving treatments. PeptiDream Inc's commitment to scientific advancement and breakthrough innovation drives its mission to improve global healthcare.

In which countries and regions is PeptiDream primarily present?

PeptiDream Inc is primarily present in Japan and the United States.

What significant milestones has the company PeptiDream achieved?

PeptiDream Inc has achieved several significant milestones. The company has successfully developed a unique peptide discovery platform called PDPS (Peptide Discovery Platform System), which enables the rapid and efficient discovery of highly diverse and functional peptide-based therapeutics. PeptiDream Inc has also established numerous collaborations with leading pharmaceutical companies to advance the development of novel peptides for various therapeutic areas. Additionally, the company has received multiple prestigious awards and recognitions for its innovative approaches and contributions to the field of peptide-based drug discovery. PeptiDream Inc continues to make remarkable progress in the discovery and development of peptide therapeutics, solidifying its position as a prominent player in the industry.

What is the history and background of the company PeptiDream?

PeptiDream Inc. is a renowned Japanese biopharmaceutical company specializing in peptide drug discovery and development. Founded in 2006, the company has established itself as a leader in the discovery and development of non-standard peptide therapeutics. PeptiDream employs its unique and proprietary Peptide Discovery Platform System (PDPS) to create a diverse library of potential drug candidates. This platform enables the rapid and efficient identification and optimization of peptide-based drugs. PeptiDream has entered into numerous partnerships with leading pharmaceutical companies globally, leveraging its expertise to explore applications in various therapeutic areas. With its innovative approach and extensive collaborations, PeptiDream continues to make significant contributions to the field of peptide drug discovery and development.

Who are the main competitors of PeptiDream in the market?

The main competitors of PeptiDream Inc in the market include Zai Lab Limited, AstraZeneca PLC, and Novartis AG.

In which industries is PeptiDream primarily active?

PeptiDream Inc is primarily active in the pharmaceutical industry.

What is the business model of PeptiDream?

PeptiDream Inc's business model revolves around peptide drug discovery and development. The company utilizes its proprietary Peptide Discovery Platform System (PDPS) to create a wide range of non-standard peptide libraries. These libraries serve as valuable sources for identifying potential drug candidates. PeptiDream collaborates with pharmaceutical and biotech companies, enabling them to access its renowned libraries. This business model allows PeptiDream to generate revenue through licensing and milestone payments. By leveraging their expertise in peptide-based therapeutics, PeptiDream Inc aims to contribute to the development of innovative drugs and enhance treatments for various diseases.

What is the P/E ratio of PeptiDream 2024?

The PeptiDream P/E ratio is 23.61.

What is the P/S ratio of PeptiDream 2024?

The PeptiDream P/S ratio is 7.52.

What is the Quality Investing of PeptiDream?

The Quality Investing for PeptiDream is 5/10.

What is the revenue of PeptiDream 2024?

The expected PeptiDream revenue is 46.62 B JPY.

How high is the profit of PeptiDream 2024?

The expected PeptiDream profit is 14.85 B JPY.

What is the business model of PeptiDream

The company PeptiDream Inc. is a biopharmaceutical company from Japan specialized in the discovery and development of peptide drug candidates. The company was founded in 2006 and is headquartered in Kawasaki City, Japan. PeptiDream utilizes a proprietary technology platform called Peptide Discovery Platform System (PDPS) to create and optimize specific peptide libraries used for the search of new peptide drug candidates. These peptides offer several advantages over traditional small molecules and proteins, including higher selectivity, efficacy, and stability. The company operates in three business areas: 1. Research and Development: PeptiDream collaborates with multinational pharmaceutical companies to develop new peptide drug candidates for various therapeutic applications. The company has partnerships with leading pharmaceutical companies such as Eli Lilly, Novartis, and Sanofi. 2. Standalone project business: PeptiDream also develops its own peptide drug candidates and conducts pre-clinical and clinical studies to test their efficacy and safety. The company has several programs for the development of peptide drug candidates in the areas of oncology, anti-allergy, and metabolism. 3. Platform technology: PeptiDream also offers its PDPS technology platform as a service. Companies can utilize this platform to quickly and effectively create and optimize their own peptide libraries. PeptiDream has a wide range of products utilized both for partnerships and its own development programs. Some of the products include: 1. PDPS technology: Peptide Discovery Platform System (PDPS) is a proprietary technology platform by PeptiDream. It is a fast and effective method for the creation and optimization of peptide libraries. 2. Peptide drug candidates: PeptiDream has created an extensive peptide library with potential drug candidates for various therapeutic applications. These peptides are used for drug development. 3. Peptides for partners: PeptiDream collaborates with multinational pharmaceutical companies to develop new peptide drug candidates for various therapeutic applications. The company also provides its partners with access to its peptide library and PDPS technology platform. Overall, PeptiDream is an innovative company developing peptide drug candidates for a wide range of therapeutic applications. The company has utilized its PDPS technology platform as a key to success and has established itself as a preferred partner for multinational pharmaceutical companies.

What is the PeptiDream dividend?

PeptiDream pays a dividend of 0 JPY distributed over payouts per year.

How often does PeptiDream pay dividends?

The dividend cannot currently be calculated for PeptiDream or the company does not pay out a dividend.

What is the PeptiDream ISIN?

The ISIN of PeptiDream is JP3836750004.

What is the PeptiDream WKN?

The WKN of PeptiDream is A1W0KK.

What is the PeptiDream ticker?

The ticker of PeptiDream is 4587.T.

How much dividend does PeptiDream pay?

Over the past 12 months, PeptiDream paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PeptiDream is expected to pay a dividend of 0 JPY.

What is the dividend yield of PeptiDream?

The current dividend yield of PeptiDream is .

When does PeptiDream pay dividends?

PeptiDream pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PeptiDream?

PeptiDream paid dividends every year for the past 0 years.

What is the dividend of PeptiDream?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is PeptiDream located?

PeptiDream is assigned to the 'Health' sector.

Wann musste ich die Aktien von PeptiDream kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PeptiDream from 11/3/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 11/3/2024.

When did PeptiDream pay the last dividend?

The last dividend was paid out on 11/3/2024.

What was the dividend of PeptiDream in the year 2023?

In the year 2023, PeptiDream distributed 0 JPY as dividends.

In which currency does PeptiDream pay out the dividend?

The dividends of PeptiDream are distributed in JPY.

All fundamentals about PeptiDream

Our stock analysis for PeptiDream Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PeptiDream Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.